Molecular pathways: protein methyltransferases in cancer.

@article{Copeland2013MolecularPP,
  title={Molecular pathways: protein methyltransferases in cancer.},
  author={Robert A Copeland},
  journal={Clinical cancer research : an official journal of the American Association for Cancer Research},
  year={2013},
  volume={19 23},
  pages={6344-50}
}
The protein methyltransferases (PMT) constitute a large and important class of enzymes that catalyze site-specific methylation of lysine or arginine residues on histones and other proteins. Site-specific histone methylation is a critical component of chromatin regulation of gene transcription-a pathway that is often genetically altered in human cancers. Oncogenic alterations (e.g., mutations, chromosomal translocations, and others) of PMTs, or of associated proteins, have been found to confer… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 19 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 47 references

Histone H3 lysine 36 dimethylation (H3K36me2) is sufficient to recruit the Rpd3s histone Research

  • B Li, J Jackson, MD Simon, B Fleharty, M Gogol, C Seidel
  • on August
  • 2013
Highly Influential
5 Excerpts

Preclinical Characterization of a Potent, Selective Inhibitor of the Protein Methyltransferase DOT1L for Use in the Treatment of MLL‐Rearranged Leukemia

  • RM Pollock, SR Daigle, CA Therkelsen, A Basavapathruni, L Jin, CJ Allain
  • ASH Annual Meeting Abstracts2012 November
  • 2012
Highly Influential
4 Excerpts

A DOT 1 L inhibitor blocks MLL - fusion leukemia

  • OhavaEJ Daigle SR, TherkelsenCA, A Basavapathruni, L Jin, A Boriack-Sjodin
  • Blood
  • 2013

Similar Papers

Loading similar papers…